Sabre Capital Investment Managers
Sabre, CDC lead $26m Series C for India's Portea
Sabre Partners and CDC Group have co-led a $26 million Series C round for Indian home healthcare business Portea Medical.
India biopharma player Vyome gets $14m Series C
Indian biopharmaceutical company Vyome Biosciences has raised a $14 million Series C funding round led by US investors Perceptive Advisors and Romulus Capital.
Sabre leads $8m round for Indian dermatology specialist
Sabre Partners as led an $8 million Series B round of funding for Vyome Biosciences, an Indian bio-pharmaceutical company that specializes in dermatology.
Sabre sells Australia’s Fudge hair care to PZ Cussons
Sabre has sold Australia’s Fudge hair care brand to PZ Cussons, the company behind Imperial Leather Soap, for GBP25.5 million ($39.5 million). The acquisition is intended to increase PZ Cussons’ exposure to the male grooming sector. Its product portfolio...
Sabre Capital-backed Spring Healthcare to invest in Indian hospital groups
Sabre Capital-owned Spring Healthcare is reportedly set to infuse approximately INR100 crore ($21.6 million) in two Indian hospital groups in Tier Two cities, which could potentially give it as much as 40% in each group.